VC-backed Scholar Rock debuts IPO
Scholar Rock, a biotech company focused on developing medicines that treat serious diseases, has raised over $75 million for its IPO after pricing its 5.36 million shares at $14 per share. The stock began trading May 24, 2018 on the NASDAQ under the ticker symbol of “SRRK." Jefferies LLC, Cowen and Company LLC and BMO Capital Markets Corp are the lead underwriters. Scholar Rock's pre-IPO investors included Invus, Redmile Group, Polaris Partners, ARCH Venture Partners, EcoR1 Capital, The Kraft Group, Fidelity Management and Research Company and Cormorant Asset Management.
24 May 2018•3 mins read
